Celularity (CELU) Interest Expenses (2020 - 2025)
Celularity's (CELU) quarterly Interest Expenses came in at $897000.0 in Q4 2025, down 50.5% year-over-year from $1.8 million in Q4 2024, and down 39.27% quarter-over-quarter from $1.5 million in Q3 2025.
Analysis
Celularity (CELU) Interest Expenses (2020 - 2025) Analysis & Trends
Celularity (CELU) has reported Interest Expenses for 5 consecutive years, with $897000.0 the latest figure, recorded in Q4 2025.
- On a quarterly basis, Interest Expenses fell 50.5% year-over-year to $897000.0 in Q4 2025; TTM through Dec 2025 was $6.8 million, a 7.82% increase from a year earlier, with the FY2025 full-year figure at $6.8 million, up 7.82% from the prior year.
- Interest Expenses was $897000.0 for Q4 2025 at Celularity, down from $1.5 million in the prior quarter.
- Over five years, Interest Expenses peaked at $2.4 million in Q1 2025 and troughed at $277000.0 in Q1 2023.
- A 4-year average of $1.2 million and a median of $1.0 million in 2023 frame the typical range for Interest Expenses.
- Across the five-year window, Interest Expenses soared 314.44% in 2024 and tumbled 50.5% in 2025, its largest moves.
- Over 4 years, Interest Expenses stood at $759000.0 in 2021, then slipped by 12.65% to $663000.0 in 2023, then jumped by 173.3% to $1.8 million in 2024, then tumbled by 50.5% to $897000.0 in 2025.
- The last three Interest Expenses figures came in at $897000.0 (Q4 2025), $1.5 million (Q3 2025), and $1.9 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.22 Bn | 9.38 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.64 Bn | 3.34 Bn | 55.72 Mn | 4.00 Bn |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn | -5.80 Mn |
| 5 | uniQure | 2.98 Bn | 2.98 Bn | 5.49 Mn | 14.37 Mn |
| 6 | Beam Therapeutics | 2.52 Bn | 2.52 Bn | - | - |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn | 2.95 Mn |
| 8 | Sarepta Therapeutics | 2.15 Bn | 1.35 Bn | 251.87 Mn | - |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn | 160,000.00 |
| 10 | Celularity | 36.61 Mn | 30.43 Mn | -3.27 Mn | 897,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 897,000.00 |
| Sep 30, 2025 | 1.48 Mn |
| Jun 30, 2025 | 1.94 Mn |
| Mar 31, 2025 | 2.44 Mn |
| Dec 31, 2024 | 1.81 Mn |
| Sep 30, 2024 | 1.75 Mn |
| Jun 30, 2024 | 1.55 Mn |
| Mar 31, 2024 | 1.15 Mn |
| Dec 31, 2023 | 663,000.00 |
| Sep 30, 2023 | 971,000.00 |
| Jun 30, 2023 | 1.10 Mn |
| Mar 31, 2023 | 277,000.00 |
| Dec 31, 2021 | 759,000.00 |
| Sep 30, 2021 | 843,000.00 |
| Jun 30, 2021 | 817,000.00 |
| Mar 31, 2021 | 752,000.00 |
| Dec 31, 2020 | 724,000.00 |
| Sep 30, 2020 | 706,000.00 |